White-Coat Hypertension and Risk Factors in Recently Diagnosed Hypertensive Patients.

Raúl Aguirre-Ramos; Benjamín Trujillo-Hernández; Miguel Huerta; Xóchitl Trujillo; Clemente Vásquez; Rebeca O. Millán-Guerrero

2002, Number 4

<< Back Next >>

Gac Med Mex 2002; 138 (4)

White-Coat Hypertension and Risk Factors in Recently Diagnosed Hypertensive Patients.

Aguirre-Ramos R, Trujillo-Hernández B, Huerta M, Trujillo X, Vásquez C, Millán-Guerrero RO

Full text

How to cite this article

Language: Spanish
References: 23
Page: 319-
PDF size: 40.88 Kb.

ABSTRACT

Objective: To determine the frequency of white-coat hypertension (WCH) and associated risk factors in recently diagnosed hypertensive patients. Material and Methods: A cross-sectional study was carried out from January 1997 to December 1998. The reference population consisted of 195 patients presenting with systemic arterial hypertension (SAH) of less than 1-month evolution and receiving no medical treatment. According to Joint National Committee (JNCVI) criteria, 100 individuals with Stages I, II, and III SAH underwent the following procedures: clinical history; physical examination; electrocardiogram, serum creatinine; urianalysis, and ambulatory monitoring of arterial pressure (AMAP). Results: A total of 54% of patients were WCH carriers and 46% presented sustained hypertension (SH); 37% of WCH patients and 63% of SH patients had a family history of SAH, while 19.7% of WCH patients and 39.2% of SH patients presented with stage I retinopathy. Left ventricular hypertrophy was absent in all WCH patients and present in 21.7% of SH patients. A total of 31% of WCH patients and 50% of SH patients presented electrocardiographic changes. Conclusions: A total of 54% of patients presented WCH. Clinical/epidemiologic profiles of WCH carriers and SH patients are different.

REFERENCES

1. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999;34:267-272.
2. Pickering TG, Coasts A, Mallion JM, Mancia G, Verdecchia P. Task force V: white coat hypertension. Blood Press Monit 1999;4(6):333-341.
3. Staessen JA, Beilin L, Parati G, Waeber B, White W. Task Force IV: clinical use of ambulatory blood pressure monitoring. Blood Press Monit 1999;4(6):319-331.
4. Middeke M, Lemmer B. Office hypertensión: abnormal blood pressure regulation and increased sympathetic activity compared with normotension. Blood Pressure Monit 1996;1:403-407.
5. Mancia G, Parati G, Pomidossi G, Gras G, Casadei R, Zanchetti A. Alerting reactions and rise in blood pressure during measurement by physician and nurse. Hyper-tension 1987;9:209-215.
6. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNCVI). Arch Intern Med 1997;157:2413-2446.
7. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of "normal" ambulatory blood pressure: implications in the assessment of white coat hypertensión. Hypertension 1992;20:555-562.
8. MacDonald M, Laing G, Wilson M, Wilson T. Prevalence and predictors of white-coat response in patients with treated hipertension. Can Med Assoc J 1999;161(3):265-269.
9. Myers MG, Reeves RA. White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens 1995;9:729-733.
Weber MA, Neutel JM. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90(5):2291-2298.
Simon P. Ambulatory blood pressure determination (editorial). Presse-Med 1994;23(27):1241-1242.
Pickering TG, Coasts A, Mallion JM, Mancia G, Verdecchia P. Task force V: white coat hypertension. Blood Press Monit 1999;4(6):333-341.
Verdecchia P, Porcellati C. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24(6):793-801.
Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999;318:593-596.
O'Brien E, Petrie J, Littler WA, de Swiet M, Padfield PL, Altman D, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993;11(Suppl 2):43-63S.
O'Brien E. Automated blood pressure measurement: state of the market in 1998 and the need for an international validation protocol for blood pressure measuring devices. Blood Press Monit 1998;3:205-211.
International Society of Hypertension. Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999;17:151-183.
Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964;1:296-30.
Bruce NG, Shaper AG, Walker M, Wannamethee G. Observer bias in blood pressure studies. J Hypertens 1988;6:375-380.
O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA, de Swiet M, Mee F. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000;320:1128-1134.
Verdecchia P. White-coat hypertension in adults and children. Blood Press Monit 1999;4:175-179.
Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993;118:867-82.
Kleinert HD, Harshfield GA, Pickering TG, Devereux RB, Sullivan PA, Marion RM, Mallory WK, Laragh JH. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension 1984; 6(4):574-8.